697 related articles for article (PubMed ID: 33392659)
21. Identification of genomic alterations in nasopharyngeal carcinoma and nasopharyngeal carcinoma-derived Epstein-Barr virus by whole-genome sequencing.
Tu C; Zeng Z; Qi P; Li X; Guo C; Xiong F; Xiang B; Zhou M; Liao Q; Yu J; Li Y; Li X; Li G; Xiong W
Carcinogenesis; 2018 Dec; 39(12):1517-1528. PubMed ID: 30102338
[TBL] [Abstract][Full Text] [Related]
22. Circulation EBV Mir-Bart-7 Relating to Clinical Manifestation in Nasopharyngeal Carcinoma.
Wardana T; Gunawan L; Herawati C; Oktriani R; Anwar S; Astuti I; Aryandono T; Mubarika S
Asian Pac J Cancer Prev; 2020 Sep; 21(9):2777-2782. PubMed ID: 32986380
[TBL] [Abstract][Full Text] [Related]
23. The Glypican-4 Gene Polymorphism rs1048369 and Susceptibility to Epstein-Barr Virus-Positive and -Negative Nasopharyngeal Carcinoma in Northern China.
Liu S; Liu W; Zhao D; Zhang Y; Zhao Z; Luo B
Oncol Res Treat; 2019; 42(11):572-579. PubMed ID: 31522169
[TBL] [Abstract][Full Text] [Related]
24. Association between HLA alleles and Epstein-Barr virus Zta-IgA serological status in healthy males from southern China.
Yuan LL; Deng CM; Xue WQ; He YQ; Wang TM; Zhang JB; Yang DW; Zhou T; Wu ZY; Liao Y; Zheng MQ; Li DH; Cao LJ; Jia YJ; Zhang WL; Xiao RW; Luo LT; Tong XT; Wu YX; Huang JW; Jia WH
J Gene Med; 2021 Nov; 23(11):e3375. PubMed ID: 34164868
[TBL] [Abstract][Full Text] [Related]
25. Nasopharyngeal brushing: a convenient and feasible sampling method for nucleic acid-based nasopharyngeal carcinoma research.
Zhang PF; Zheng XH; Li XZ; Tian T; Zhang SD; Hu YZ; Jia WH
Cancer Commun (Lond); 2018 Apr; 38(1):8. PubMed ID: 29764493
[TBL] [Abstract][Full Text] [Related]
26. High Levels of Antibody that Neutralize B-cell Infection of Epstein-Barr Virus and that Bind EBV gp350 Are Associated with a Lower Risk of Nasopharyngeal Carcinoma.
Coghill AE; Bu W; Nguyen H; Hsu WL; Yu KJ; Lou PJ; Wang CP; Chen CJ; Hildesheim A; Cohen JI
Clin Cancer Res; 2016 Jul; 22(14):3451-7. PubMed ID: 26920891
[TBL] [Abstract][Full Text] [Related]
27. Polymorphism analysis of Epstein-Barr virus isolates of nasopharyngeal carcinoma biopsies from Tunisian patients.
Ayadi W; Feki L; Khabir A; Boudawara T; Ghorbel A; Charfeddine I; Daoud J; Frikha M; Hammami A; Karray-Hakim H
Virus Genes; 2007 Apr; 34(2):137-45. PubMed ID: 17216568
[TBL] [Abstract][Full Text] [Related]
28. Systematic comparison of plasma EBV DNA, anti-EBV antibodies and miRNA levels for early detection and prognosis of nasopharyngeal carcinoma.
Tan LP; Tan GW; Sivanesan VM; Goh SL; Ng XJ; Lim CS; Kim WR; Mohidin TBBM; Mohd Dali NS; Ong SH; Wong CY; Sawali H; Yap YY; Hassan F; Pua KC; Koay CE; Ng CC; Khoo AS;
Int J Cancer; 2020 Apr; 146(8):2336-2347. PubMed ID: 31469434
[TBL] [Abstract][Full Text] [Related]
29. MICA-129 Dimorphism and Soluble MICA Are Associated With the Progression of Multiple Myeloma.
Zingoni A; Vulpis E; Cecere F; Amendola MG; Fuerst D; Saribekyan T; Achour A; Sandalova T; Nardone I; Peri A; Soriani A; Fionda C; Mariggiò E; Petrucci MT; Ricciardi MR; Mytilineos J; Cippitelli M; Cerboni C; Santoni A
Front Immunol; 2018; 9():926. PubMed ID: 29765374
[TBL] [Abstract][Full Text] [Related]
30. Epstein-Barr virus mRNA profiles and viral DNA methylation status in nasopharyngeal brushings from nasopharyngeal carcinoma patients reflect tumor origin.
Ramayanti O; Juwana H; Verkuijlen SA; Adham M; Pegtel MD; Greijer AE; Middeldorp JM
Int J Cancer; 2017 Jan; 140(1):149-162. PubMed ID: 27600027
[TBL] [Abstract][Full Text] [Related]
31. Differences in cancer gene copy number alterations between Epstein-Barr virus-positive and Epstein-Barr virus-negative nasopharyngeal carcinoma.
Ooft ML; van Ipenburg J; van de Loo RJM; de Jong R; Moelans CB; de Bree R; de Herdt MJ; Koljenović S; Baatenburg de Jong R; Hardillo J; Willems SM
Head Neck; 2018 Sep; 40(9):1986-1998. PubMed ID: 29927011
[TBL] [Abstract][Full Text] [Related]
32. Association of Epstein Barr virus A73 gene polymorphism with nasopharyngeal carcinoma.
Shen JJ; Niu WN; Zhou M; Zhou F; Zhang HY; Wang L
Genet Test Mol Biomarkers; 2015 Apr; 19(4):187-90. PubMed ID: 25275219
[TBL] [Abstract][Full Text] [Related]
33. Association of MICA-129 polymorphism with nasopharyngeal cancer risk in a Tunisian population.
Douik H; Ben Chaaben A; Attia Romdhane N; Romdhane HB; Mamoghli T; Fortier C; Boukouaci W; Harzallah L; Ghanem A; Gritli S; Makni M; Charron D; Krishnamoorthy R; Guemira F; Tamouza R
Hum Immunol; 2009 Jan; 70(1):45-8. PubMed ID: 19000729
[TBL] [Abstract][Full Text] [Related]
34. Host genetic variants, Epstein-Barr virus subtypes, and the risk of nasopharyngeal carcinoma: Assessment of interaction and mediation.
Xu M; Feng R; Liu Z; Zhou X; Chen Y; Cao Y; Valeri L; Li Z; Liu Z; Cao SM; Liu Q; Xie SH; Chang ET; Jia WH; Shen J; Yao Y; Cai YL; Zheng Y; Zhang Z; Huang G; Ernberg I; Tang M; Ye W; Adami HO; Zeng YX; Lin X
Cell Genom; 2024 Feb; 4(2):100474. PubMed ID: 38359790
[TBL] [Abstract][Full Text] [Related]
35. Prognostic role of tumour-associated macrophages and regulatory T cells in EBV-positive and EBV-negative nasopharyngeal carcinoma.
Ooft ML; van Ipenburg JA; Sanders ME; Kranendonk M; Hofland I; de Bree R; Koljenović S; Willems SM
J Clin Pathol; 2018 Mar; 71(3):267-274. PubMed ID: 28877959
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of Risk Factors for Nasopharyngeal Carcinoma in a High-risk Area of India, the Northeastern Region.
Lourembam DS; Singh AR; Sharma TD; Singh TS; Singh TR; Singh LS
Asian Pac J Cancer Prev; 2015; 16(12):4927-35. PubMed ID: 26163617
[TBL] [Abstract][Full Text] [Related]
37. Epstein-Barr Virus Induces Adipocyte Dedifferentiation to Modulate the Tumor Microenvironment.
Liu SC; Tsang NM; Lee PJ; Sui YH; Huang CH; Liu TT
Cancer Res; 2021 Jun; 81(12):3283-3294. PubMed ID: 33824135
[TBL] [Abstract][Full Text] [Related]
38. Analysis of the Expression of Surface Receptors on NK Cells and NKG2D on Immunocytes in Peripheral Blood of Patients with Nasopharyngeal Carcinoma.
Xu Y; Zhou R; Huang C; Zhang M; Li J; Zong J; Qiu S; Lin S; Chen H; Ye Y; Pan J
Asian Pac J Cancer Prev; 2018 Mar; 19(3):661-665. PubMed ID: 29580037
[TBL] [Abstract][Full Text] [Related]
39. Clinical utility of circulating Epstein-Barr virus DNA analysis for the management of nasopharyngeal carcinoma.
Fung SY; Lam JW; Chan KC
Chin Clin Oncol; 2016 Apr; 5(2):18. PubMed ID: 27121878
[TBL] [Abstract][Full Text] [Related]
40. Genome-Wide Analysis of 18 Epstein-Barr Viruses Isolated from Primary Nasopharyngeal Carcinoma Biopsy Specimens.
Tu C; Zeng Z; Qi P; Li X; Yu Z; Guo C; Xiong F; Xiang B; Zhou M; Gong Z; Liao Q; Yu J; He Y; Zhang W; Li X; Li Y; Li G; Xiong W
J Virol; 2017 Sep; 91(17):. PubMed ID: 28637758
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
